Azitra, Inc. , a clinical-stage biopharmaceutical company focused on developing innovative therapies for precision dermatology, today announced that it has entered into a securities purchase agreement ...
We recently raised an additional $3M in seed funding, bringing our total to $11M since we launched in 2023. This investment was co-led by our existing lead investors, A* and Maverick Ventures, who ...
"The investment property mortgage industry is traditionally serviced by Fannie, Freddie, small and hard money lenders, leading to limited liquidity and tech advancement, and a disjointed high-cost ...